← Back to headlines
Lantern Pharma Projects $15B–$20B Market Potential Amid AI Pipeline Advancement
Lantern Pharma has outlined a market potential of $15 billion to $20 billion as its AI-driven drug pipeline advances, indicating intensifying funding needs for its future growth.
30 Mar, 23:53 — 30 Mar, 23:53
Sources
Showing 1 of 1 sources



